T2 Biosystems Sees Prelim. Q3 Revenue ~$3.7M
Achieved estimated third quarter total revenue of approximately $3.7 million, including estimated product revenue of approximately $2.6 million, representing decreases
T2 Biosystems Announces BARDA Exercise Of Contract Option 3 Valued At $3.7M
LEXINGTON, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers
Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday.
11 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers
Rubius Therapeutics (NASDAQ:RUBY) shares moved upwards by 30.46% to $0.59. The market value of their outstanding shares is at $53.5 million.
T2 Biosystems Stock Jumps On Distribution Pact In Baltic Countries
T2 Biosystems Inc (NASDAQ:TTOO) executed a territory-exclusive distribution agreement in the Baltic Region, including Lithuania, Latvia, and Estonia. Under the terms…
